Latest Breaking News On - Institutional investors weigh in on arrowhead pharmaceuticals - Page 1 : comparemela.com

Arrowhead Pharmaceuticals (ARWR) Buy Rating Reaffirmed at Chardan Capital

Arrowhead Pharmaceuticals (ARWR) Buy Rating Reaffirmed at Chardan Capital
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesHongbo luArrowhead pharmaceuticals price performanceWashington trust advisors incArrowhead pharmaceuticals company profileArrowhead pharmaceuticalsArrowhead pharmaceuticals incQuest partnersThird bancorpFifth third bancorpAnalyst recommendations for arrowhead pharmaceuticalsMorgan stanleyRoyal bankNews ratings for arrowhead pharmaceuticals dailyInstitutional investors weigh in on arrowhead pharmaceuticalsSecurities exchange commission

Arrowhead Pharmaceuticals (NASDAQ:ARWR) Releases Earnings Results, Misses Expectations By $0 46 EPS

Arrowhead Pharmaceuticals (NASDAQ:ARWR) Releases Earnings Results, Misses Expectations By $0 46 EPS
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesChristopher richard anzaloneTopco ltdInsider activity at arrowhead pharmaceuticalsDelphia united states incNews ratings for arrowhead pharmaceuticals dailyArrowhead pharmaceuticals incSecurities exchange commissionMorgan stanleyWealth conceptsArrowhead pharmaceuticalsEarnings history for arrowhead pharmaceuticalsRoyal bankCim investment management incArrowhead pharmaceuticals price performanceInstitutional investors weigh in on arrowhead pharmaceuticals

Arrowhead Pharmaceuticals (ARWR) Scheduled to Post Earnings on Monday

Arrowhead Pharmaceuticals (ARWR) Scheduled to Post Earnings on Monday
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Hong kongUnited statesChristopher richard anzaloneMorgan stanleyAdvisors asset management incArrowhead pharmaceuticals stock performanceArrowhead pharmaceuticalsArrowhead pharmaceuticals company profileLazard asset managementNews ratings for arrowhead pharmaceuticals dailyInsider activity at arrowhead pharmaceuticalsHong kong ltdInstitutional investors weigh in on arrowhead pharmaceuticalsEarnings history for arrowhead pharmaceuticalsSecurities exchange commissionArrowhead pharmaceuticals inc

Arrowhead Pharmaceuticals, Inc (NASDAQ:ARWR) Director Douglas B Given Sells 2,911 Shares

Arrowhead Pharmaceuticals, Inc (NASDAQ:ARWR) Director Douglas B Given Sells 2,911 Shares
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Nova scotiaUnited statesArrowhead pharmaceuticals incCommonwealth of pennsylvania public school empls retrmtArrowhead pharmaceuticalsQuarter for arrowhead pharmaceuticalsUs bancorpInstitutional investors weigh in on arrowhead pharmaceuticalsBlackrock incNews ratings for arrowhead pharmaceuticals dailyRoyal bankMorgan stanleyHightower advisorsArrowhead pharmaceuticals trading downGet free reportDirector douglas

Victoria Vakiener Sells 1,550 Shares of Arrowhead Pharmaceuticals, Inc (NASDAQ:ARWR) Stock

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Get Free Report) Director Victoria Vakiener sold 1,550 shares of the company’s stock in a transaction dated Thursday, September 28th. The stock was sold at an average price of $26.33, for a total transaction of $40,811.50. Following the sale, the director now directly owns 21,734 shares of the company’s stock, […]

United statesNorges bankRoyal bankMillennium managementInstitutional investors weigh in on arrowhead pharmaceuticalsQuarter for arrowhead pharmaceuticalsDriehaus capital managementNomura holdings incArrowhead pharmaceuticalsNews ratings for arrowhead pharmaceuticals dailyArrowhead pharmaceuticals stock downArrowhead pharmaceuticals incSecurities exchange commissionGet free reportDirector victoria vakienerExchange commission